Provided by Tiger Trade Technology Pte. Ltd.

JPMORGAN HEALTHCARE LEADERS ETF

61.55
+0.46990.77%
Post-market: 61.08-0.4699-0.76%16:10 EDT
Volume:23
Turnover:1K
Market Cap:9.23M
PE:- -
High:61.55
Open:61.08
Low:61.55
Close:61.08
52wk High:64.69
52wk Low:50.34
Shares:150.00K
Float Shares:150.00K
Volume Ratio:0.13
T/O Rate:0.02%
Dividend:0.51
Dividend Rate:0.83%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Twist Bioscience Corporation - to Provide Antibody Characterization Data Services for Lilly Tunelab

THOMSON REUTERS
·
Sep 16

Circle Pharma: Financing Led by Column Group, Participation from Nextech Invest, Ra Capital Management, Strategic Investment from Eli Lilly and Co

THOMSON REUTERS
·
Sep 16

Kailera Therapeutics to Participate in September Investor Conferences

GlobeNewswire
·
Sep 16

Actinogen Medical Options Expire, Streamlining ASX-Listed Capital Structure

TIPRANKS
·
Sep 16

Cambium Bio Plans New Share Placement to Bolster Capital Base

TIPRANKS
·
Sep 16

Estee Lauder Cos. Cl a Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 16

UnitedHealth Group Announces Earnings Release Date

THOMSON REUTERS
·
Sep 16

Health Rounds: New Dye for MRI Exams Detects Lung Cancer Earlier

Reuters
·
Sep 16

Thatch Raises $108 Million at $1 Billion Valuation

Reuters
·
Sep 16

Thatch: Funding & Participation from the General Partnership, General Catalyst, Andreessen Horowitz, ADP Ventures, Eli Lilly & Others

THOMSON REUTERS
·
Sep 16

LIVE Markets-from Ozempic Face to K-Beauty Factories: the Next Beauty Bet

Reuters
·
Sep 15

As Trump Backs Psychedelics Research, FDA Weighs Safety and Access Standards

Reuters
·
Sep 15

LIVE Markets-Autumn in New York: Factory Expansion Slows, Input Prices at Multi-Year Highs - Empire State

Reuters
·
Sep 15

Eli Lilly Stock (LLY) Gets New Buy Rating as Weight-Loss Drug Sales Accelerate

TIPRANKS
·
Sep 15

LIVE Markets-US Stock Indexes Swing Lower as Oil, Yields Jump

Reuters
·
Sep 15

Abbvie Exec Says Will Present Late-Stage Data for Blood Cancer Drug Etentamig at International Myeloma Society Meeting Later in September - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Existing Portfolio Provides 'Clear Line of Sight' to Very Strong Growth Well into Next Decade - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Apogee Fits 'Very Nicely' with Its Business Development Approach - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Plans to Start Enrolling Apogee's Zumilokibart This Year, Targets Launch in Early 2030 - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Tavapadon U.S. Launch Expected to Have 'Slower Burn' Due to Timing of Medicare Reimbursement - Conf Call

THOMSON REUTERS
·
Sep 15